MedPath

HEALTHCARE PHARMASCIENCE LIMITED

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

195

PPB:195

Drug Approvals

ACYRIX TABLETS 400MG

Approval Date
Jun 19, 2025
PPB

RYMONT TABLETS 10MG

Approval Date
Jun 12, 2025
PPB

COLAXIN POWDER FOR ORAL SUSPENSION 125MG/5ML

Approval Date
May 29, 2025
PPB

SPILAX GASTRO-RESISTANT TABLETS 5MG

Approval Date
May 27, 2025
PPB

VOLCLONAX GASTRO-RESISTANT TABLETS 25MG

Approval Date
Mar 20, 2025
PPB

VOLCLONAX GASTRO-RESISTANT TABLETS 50MG

Approval Date
Mar 20, 2025
PPB

DOMINIX ORAL SUSPENSION 5MG/5ML

Approval Date
Nov 15, 2024
PPB

SPIROLON 25 TABLETS 25MG

Approval Date
Mar 10, 2023
PPB

SPIROLON 100 TABLETS 100MG

Approval Date
Mar 10, 2023
PPB

PIROTOP OINTMENT 2% W/W

Approval Date
Jan 26, 2023
PPB
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 20
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.